Drugmaker shares drop after RFK Jr. tapped to lead HHS
- Shares in vaccine makers and healthcare firms dropped sharply after Robert F Kennedy Jr was tapped as US Health Secretary, raising investor concerns about the sector.
- Kennedy has stated he will use the position to crack down on 'Big Pharma,' which has led to fears of increased anti-vaccine rhetoric.
- Health policy experts believe this could deter Americans from receiving Covid shots and routine immunizations, as noted by former CDC Director Dr. Richard Besser.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
Drugmaker Stocks Slide as Trump Taps Vaccine Skeptic RFK Jr for US Health Job
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
·New York, United States
Read Full ArticleVaccine-maker stocks like Moderna, Pfizer drop as Trump taps RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the U.S. Department of Health and Human Services.
·United States
Read Full ArticleDrugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job
Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F. Kennedy Jr. to head the Department of Health and Human Services, the top U.S. health agency.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources17
Leaning Left2Leaning Right5Center7Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
14%
C 50%
R 36%
Factuality
To view factuality data please Upgrade to Premium